Well Referenced

Tag: NAD⁺ metabolism

Role of NAD(+), Oxidative Stress, and Tryptophan Metabolism in Autism Spectrum Disorders

This 2013 review examines the biochemical underpinnings of autism spectrum disorder (ASD), focusing on oxidative stress, mitochondrial dysfunction, and tryptophan metabolism. It highlights that individuals with ASD often exhibit elevated oxidative stress markers and diminished antioxidant defenses, leading to mitochondrial impairments and disrupted energy metabolism, including alterations in NAD⁺/NADH ratios

Read More »
June 26, 2025 No Comments

Nicotinamide riboside is uniquely and orally bioavailable in mice and humans

This 2016 study evaluated the pharmacokinetics and bioavailability of nicotinamide riboside (NR), a vitamin B3 derivative, in both mice and humans. In mice, oral NR administration led to significant increases in hepatic NAD⁺ levels, outperforming other NAD⁺ precursors like nicotinic acid and nicotinamide. In a human pilot study, a single

Read More »
June 26, 2025 No Comments

Impaired Nicotinamide Adenine Dinucleotide (NAD⁺) Metabolism in Diabetes and Diabetic Tissues: Implications for Nicotinamide-Related Compound Treatment

This 2020 review explores how diabetes disrupts NAD⁺ metabolism, leading to reduced NAD⁺/NADH ratios (pseudohypoxia) due to increased substrate oxidation. In type 1 diabetes, NAD⁺ depletion is driven by poly(ADP-ribose) polymerase (PARP) activation, while in type 2 diabetes, decreased AMP-activated protein kinase (AMPK) activity impairs NAD⁺ biosynthesis via downregulation of

Read More »
June 26, 2025 No Comments

NAD⁺ Metabolism in Cardiac Health, Aging, and Disease

This comprehensive review examines the pivotal role of NAD⁺ in cardiac physiology, aging, and disease. It details how NAD⁺ levels decline with age, obesity, and hypertension, contributing to cardiovascular diseases. The article discusses mechanisms of NAD⁺ metabolism in cardiomyocytes, including biosynthesis and degradation pathways, and the impact on mitochondrial function

Read More »
June 26, 2025 No Comments

Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD⁺ in healthy middle-aged and older adults

This 2018 randomized, double-blind, placebo-controlled, crossover trial evaluated the effects of 6 weeks of oral nicotinamide riboside (NR) supplementation (500 mg twice daily) in 24 healthy adults aged 55–79. NR significantly increased NAD⁺ levels in peripheral blood mononuclear cells by approximately 60% compared to placebo. Exploratory analyses indicated potential reductions

Read More »
June 26, 2025 No Comments